Vasopressin Injection
Product Images NDC 51662-1623

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Vasopressin (NDC 51662-1623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1623 1 Serialized Rfid Label)

FDA Label Image

Vial Label (51662 1623 1 Vial Label)

Vial Label (51662 1623 1 Vial Label)
This is a prescription drug called Vasopressin, and it comes in a 20 Units per mL Injection that must be diluted before use. It is stored in a vial that must be kept between 2°C and 8°C (36°F to 46°F), and should not be used if it remained open for more than 48 hours. The drug is manufactured in India for a company called "UroMedics Pharma LLC" located in E. Windsor, NJ 08520. The full prescribing information should be consulted for the usual dosage.*
FDA Label Image

Pouch (51662 1623 2 Serialized Pouch Labeling)

Pouch (51662 1623 2 Serialized Pouch Labeling)
This is a description of an injectable medication called Vasopressin. The container includes 2 units of Vasopressin per milliliter of solution. It is intended for intravenous infusion only and must be diluted before use. The usual dosage depends on the patient's needs and medical condition. The solution contains Chlorobutanol and acid as an additive. The container also provides specific storage instructions for the medication, including the recommended temperature range and maximum storage time. The medication should be used within a few hours after initial administration. The packaging includes the manufacturer's information, NDC number, and a lot and expiration date. The medicament is prescription-only.*
FDA Label Image

Serialized Rfid Pouch Labeling (51662 1623 2 Serialized Rfid Labeling)

FDA Label Image

Structure (Description)

FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
The text provides a table (Table 1) that outlines the preparation of diluted solutions for Vasopressin injection. The table lists the final concentration of the mixture based on whether fluid restriction is necessary. If there is no fluid restriction, the final concentration is 0.1 units/mL, and the mix contains 2.5 mL (50 units) of Vasopressin injection in 500 mL of diluent. Alternatively, if fluid restriction is required, the final concentration is 1 unit/mL, and the mix contains 5 mL (100 units) of Vasopressin injection in 100 mL of diluent.*
FDA Label Image

Storage And Handling (How Supplied Storage)

Storage And Handling (How Supplied Storage)
This is a description of how to properly store and use a 1 mL vial medication. If unopened, it should be stored refrigerated between 2°C to 8°C (36°F to 46°F), or at room temperature between 20°C to 25°C (68°F to 77°F), but not above 25°C (77°F). If opened, it can be used until the manufacturer expiration date or for up to 12 months, whichever comes first, but must be used within 48 hours after the first puncture.*
FDA Label Image

Vial Label (Vial Label 1623 2)

Vial Label (Vial Label 1623 2)
This is a product information label for Vasopressin injection, USP manufactured in India for JuroMedics Pharma. It is a synthetic medication that comes in a 1ml multiple dose vial with 20 units per mL, and is used for intravenous infusion after dilution. The label specifies the storage temperature, usual dosage and expiry date of the medication, and also mentions that the remaining contents in the vial should be used within 48 hours of initial entry. The code at the end appears to be a reference number for tracking or inventory purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.